Skip to main content
. 2022 Nov 18;4(12):588–594. doi: 10.1253/circrep.CR-22-0109

Figure 3.

Figure 3.

(A,B) Correlations between changes in HbA1c after sacubitril/valsartan treatment (∆HbA1c) and N-terminal pro B-type natriuretic peptide (NT-proBNP) concentrations before (baseline; A) and after (∆NT-proBNP; B) sacubitril/valsartan treatment in 90 patients who had NT-proBNP tested. There were no correlations between ∆HbA1c and either baseline NT-proBNP (Spearman’s rank correlation coefficient: 0.032; P=0.761) or ∆NT-proBNP (Spearman’s rank correlation coefficient: 0.057; P=0.593). (C) There was no correlation between ∆HbA1c and ∆NT-proBNP in diabetic patients with a ventricular overload state (NT-proBNP >400 pg/mL) before sacubitril/valsartan treatment (n=45; Spearman’s rank correlation coefficient: 0.056; P=0.715).